Release Date: 28/02/13 16:40 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 3.9MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling